Accorto Regulatory Solutions Partners with GINN
Accorto Regulatory Solutions, a forward-thinking regulatory compliance firm, is excited to announce its official partnership with the Global Institute for Novel Nicotine (GINN). This organization is dedicated to promoting tobacco harm reduction by supporting research and development of non-vaporized tobacco alternatives for adult smokers. Through this collaboration, Accorto aims to pave the way for comprehensive, evidence-based regulations that improve public health outcomes.
About the Global Institute for Novel Nicotine
GINN is well-respected for its commitment to enhancing public health through rigorous regulatory practices in the tobacco harm reduction field. Central to GINN's mission is the Science and Standards Committee (SSC), which consists of highly qualified regulatory and scientific experts specializing in reduced-risk nicotine products. Their combined efforts help create thoughtful regulatory recommendations that strike a balance between innovation and safety.
Accorto’s Role and Commitment
Leading this initiative is Accorto's Chief Scientific Officer, Dr. Vince Angelico, who will bring invaluable expertise to the SSC. His participation marks a significant step in improving the regulatory landscape, with a focus on transparency and consumer safety. "Joining GINN is a vital milestone in our ongoing mission to advance public health and ensure a responsible market for nicotine products," said Tom Beaudet, CEO of Accorto Regulatory Solutions.
Collaboration for Public Health
Accorto's involvement with GINN represents a dedicated effort to develop scientifically grounded regulations while helping other members navigate the intricate regulatory landscape for reduced-risk products. This partnership is anticipated to provide innovative solutions for adult tobacco users seeking safer alternatives. By fostering close collaboration, Accorto aims to ensure that these alternatives meet the highest safety and efficacy standards before they enter the market.
Leadership's Vision
"This partnership with GINN enables us to strengthen our commitment to evidence-based regulations, reinforcing the integrity of the industry and prioritizing consumer safety," remarked Shem Baldeosingh, Director of GINN. This collaboration will significantly enhance the ability to create robust frameworks that support the safer marketing of these products.
Accorto Regulatory Solutions
As a leader in regulatory advisory services, Accorto specializes in guiding clients through the complex regulatory environments that impact the tobacco harm reduction and life sciences sectors. Renowned for providing tailored strategies, Accorto assists clients in efficiently introducing innovative products while ensuring compliance with all relevant regulations. The firm has built a strong reputation for its high-quality PMTA application development, achieving an impressive track record of success in navigating FDA pathways.
About GINN
GINN serves as a key advocate for non-vaping reduced-risk products, focusing on innovative alternatives such as nicotine pouches and heat-not-burn options. With a global presence, GINN employs a science-led approach that resonates with stakeholders across the industry, fostering responsible dialogue on tobacco harm reduction.
Frequently Asked Questions
What is the purpose of Accorto's partnership with GINN?
The partnership aims to promote tobacco harm reduction by facilitating science-driven regulations and supporting the development of reduced-risk nicotine alternatives.
Who is Dr. Vince Angelico?
Dr. Vince Angelico is Accorto's Chief Scientific Officer and a key member of GINN's Science and Standards Committee, bringing extensive expertise in regulatory affairs.
What does GINN focus on?
GINN focuses on advocating for non-vaping reduced-risk products and establishing a regulatory framework that embraces innovation while safeguarding public health.
How does Accorto assist clients?
Accorto helps clients navigate complex regulatory landscapes, ensuring compliance while effectively bringing innovative reduced-risk products to market.
What are reduced-risk products?
Reduced-risk products are alternatives to traditional tobacco products that aim to offer lower health risks to users, such as nicotine pouches or heat-not-burn products.
